AZN.UK

11,376

+2.52%↑

GSK

1,451.5

+2.36%↑

INDV

742

+1.5%↑

AZN.UK

11,376

+2.52%↑

GSK

1,451.5

+2.36%↑

INDV

742

+1.5%↑

AZN.UK

11,376

+2.52%↑

GSK

1,451.5

+2.36%↑

INDV

742

+1.5%↑

AZN.UK

11,376

+2.52%↑

GSK

1,451.5

+2.36%↑

INDV

742

+1.5%↑

AZN.UK

11,376

+2.52%↑

GSK

1,451.5

+2.36%↑

INDV

742

+1.5%↑

Search

Haleon PLC

Abierto

SectorSalud

392.3 1.34

Resumen

Variación precio

24h

Actual

Mínimo

385.2

Máximo

394.4

Métricas clave

By Trading Economics

Ingresos

-254M

231M

Ventas

-21M

2.8B

P/B

Media del Sector

24.456

63.778

BPA

0.042

Rentabilidad por dividendo

1.69

Margen de beneficio

8.373

Empleados

24,561

EBITDA

-317M

399M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+4.01% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.69%

2.39%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.3B

35B

Apertura anterior

390.96

Cierre anterior

392.3

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

180 / 386 Clasificación en Healthcare

Haleon PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 mar 2025, 07:34 UTC

Adquisiciones, fusiones, absorciones

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Dispose of Remaining Shareholding in Haleon

27 feb 2025, 07:43 UTC

Ganancias

Haleon Expects Further Growth After Profit Rises

18 mar 2025, 16:58 UTC

Adquisiciones, fusiones, absorciones

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar 2025, 16:57 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar 2025, 16:56 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Haleon Takes Note of Announcement

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Is Subject to Customary Closing Conditions

18 mar 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mar 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 mar 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 mar 2025, 16:46 UTC

Adquisiciones, fusiones, absorciones

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

27 feb 2025, 10:14 UTC

Charlas de Mercado
Ganancias

Haleon's EPS Beat Is Reassuring -- Market Talk

27 feb 2025, 07:58 UTC

Charlas de Mercado
Ganancias

Haleon's Results Are Consistent -- Market Talk

27 feb 2025, 07:04 UTC

Ganancias

Haleon Sees 2025 Organic Operating Profit Growth Ahead of Organic Rev Growth

27 feb 2025, 07:04 UTC

Ganancias

Haleon Backs Mid-Term Targets

27 feb 2025, 07:03 UTC

Ganancias

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

27 feb 2025, 07:03 UTC

Ganancias

Haleon 2024 EPS 15.7p

27 feb 2025, 07:03 UTC

Ganancias

Haleon 2024 Net Pft GBP1.44B

27 feb 2025, 07:03 UTC

Ganancias

Haleon 2024 Pretax Pft GBP1.91B

27 feb 2025, 07:02 UTC

Ganancias

Haleon To Allocate GBP500M For Buybacks In 2025

27 feb 2025, 07:02 UTC

Ganancias

Haleon Raises Dividend to 4.6p Vs 4.2p

27 feb 2025, 07:01 UTC

Ganancias

Analysts Saw Haleon 2024 Adj Oper Pft Margin at 22.3%

27 feb 2025, 07:01 UTC

Ganancias

Haleon 2024 Adj Oper Pft Margin 22.3%

Comparación entre iguales

Cambio de precio

Haleon PLC Esperado

Precio Objetivo

By TipRanks

4.01% repunte

Estimación a 12 meses

Media 407 GBX  4.01%

Máximo 460 GBX

Mínimo 315 GBX

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Haleon PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

4

Comprar

6

Mantener

1

Vender

Sentimiento

By Acuity

180 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.